Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-03-21

Clinical Trial Update: Effect of Warfarin in the Treatment of Metachromatic Leukodystrophy [NA]

View source ↗

Summary

This document notes that a clinical trial evaluating warfarin as a treatment for metachromatic leukodystrophy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Warfarin (warfarin)

Snippet

Sponsor: The Cooper Health System | Conditions: Metachromatic Leukodystrophy | NA | Status: COMPLETED